4/A: MacroGenics Director Files Amended Form 4 Regarding Stock Option Grant
SEC Filing
Margaret Liu, a director at MacroGenics Inc., filed an amended Form 4 to correct a previously reported stock option transaction.
Summary
- Margaret Liu, a director of MacroGenics Inc. (MGNX), filed an amended Form 4 with the SEC.
- The amendment, dated May 24, 2024, relates to a transaction originally reported on May 23, 2024.
- The filing concerns an employee stock option grant received on May 21, 2024, with an exercise price of $4.26.
- The director acquired 16,500 options, which vest monthly over a year starting one month from the grant date and expire on May 21, 2034.
- The amendment corrects an error where the transaction was inadvertently included on a previously filed Form 4 and should be deleted.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, indicating standard corporate governance practices. The amendment suggests attention to detail and compliance, which is moderately positive.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of stock option grant. |
| 05/23/2024 | Date of original Form 4 filing (amended). |
| 05/24/2024 | Date of amended Form 4 filing. |
| 05/21/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.